Vaccine description | |
---|---|
Target | Rotavirus |
Vaccine type | Attenuated |
Clinical data | |
Trade names | Rotarix, RotaTeq, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a607024 |
License data |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
KEGG | |
(what is this?) (verify) |
The rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children.[1] The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of the risk of death among young children due to severe diarrhea.[1] Immunizing babies decreases rates of disease among older people and those who have not been immunized.[2]
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common.[1] This should be done along with promoting breastfeeding, handwashing, clean water, and good sanitation.[1] It is given by mouth and requires two or three doses.[1] It should be given starting around six weeks of age.[1]
The vaccines are safe.[1] This includes their use in people with HIV/AIDS.[1] The vaccines are made from weakened rotavirus.[1]
The vaccine first became available in the United States in 2006.[3] It is on the World Health Organization's List of Essential Medicines.[4][5] As of 2013, there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.[1]